Hide Board Information

Show Board Information

CytoDyn Inc CYDY

Board Mod: HHIGambler

Asst Mods: Riztheinvestor CaptnAmerca mightycydy

Last Post: 12/27/2024 5:55:04 PM

Board Marks: 388

Posts Today: 15

Board Views Today: 54145

CytoDyn Inc. (OTCQB: CYDY)

Company Website: http://www.cytodyn.com/

CytoDyn Inc (OTCMRKTS: CYDY) Stock Message Board

1. CYDY Company Profile

    

2. CYDY Time & Sales

    

3. CYDY Recent News

    

4. CYDY Filings

    

5. CYDY Financials

    

6. CYDY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

13623	Leronlimab (Pro 140) Cliff Notes What is it? (37)	trding	12/24/2019 8:09:27 PM
112006	Leronlimab - Disease List (currently 90) (updated (28)	ohm20	12/09/2021 8:15:12 AM
144440	Leronlimab Regulator List (a work in progress) = (18)	ohm20	06/12/2024 7:33:56 PM
145805	Here's some basics on the science - Leronlimab (44)	ohm20	08/21/2024 12:48:53 PM
71195	Importantly, it now excludes patients with (1)	ClosetInvestor	01/04/2021 11:28:03 AM
71194	Must have ran it past the (1)	ohm20	01/04/2021 11:04:37 AM
71193	In addition to the eIND criteria correction, (12)	Dr Zaius	01/04/2021 11:01:52 AM
71192	Yes Ohm. I noticed that too. Wouldn't it have (1)	mtruong34	01/04/2021 10:59:49 AM
71191	It is stated a bit oddly, but the previous (1)	CTMedic	01/04/2021 10:56:34 AM
71190	Thank you for the clarification !!! GLTA	Shelly2626	01/04/2021 10:55:20 AM
71189	Todays PR was also the important clarification (1)	CTMedic	01/04/2021 10:53:43 AM
71188	That correction is stated very oddly. It's the (1)	ohm20	01/04/2021 10:52:06 AM
71187	Leronlimab's supply from Samsung is a huge (2)	Borel Fields	01/04/2021 10:50:30 AM
71186	looks like a reminder to me ......already tweeted	Shelly2626	01/04/2021 10:49:03 AM
71185	Can anyone make sense of todays PR, clearly its	Shopcop7	01/04/2021 10:46:36 AM
71184	mechanically ventilated with PEEP >=15 cmH20 (25)	SporadicE	01/04/2021 10:34:06 AM
71183	classic marx brothers news release(s). (2)	Rubraquercus	01/04/2021 10:22:10 AM
71182	Not a doc, but both now exclude the sickest. Was (2)	Borel Fields	01/04/2021 10:08:33 AM
71180	Vaccines' effectiveness in South African variant (1)	JLang	01/04/2021 10:05:35 AM
71179	I'm not a doctor but Dr. Yo was recently (1)	mtruong34	01/04/2021 10:01:28 AM
71178	Can one of our esteemed doctors on the board (1)	CaptnAmerca	01/04/2021 9:41:25 AM
71177	We can say those people were saved because	ohm20	01/04/2021 9:37:31 AM
71176	That would be an interesting long term, large	ohm20	01/04/2021 9:31:45 AM
71175	It was to correct a gross error with the eIND PR	mtruong34	01/04/2021 9:17:13 AM
71174	https://news.yahoo.com/mexican-doctor-hospitalize (1)	onestepahead	01/04/2021 9:12:59 AM
71173	Good catch! In case someone missed it: (1)	lorbas	01/04/2021 8:47:31 AM
71170	If I were on the verge of expiration I would (2)	Longestyard	01/04/2021 7:19:47 AM
71169	Probably just trying to stay active on the comms,	Longestyard	01/04/2021 7:14:22 AM
71167	GVHD/CYDY	hoops	01/04/2021 7:12:56 AM
71166	Thanks for that update. Congrats on your position	docj	01/04/2021 7:10:35 AM
71165	https://www.teletrader.com/cytodyn-inc/stocks/det (1)	biloxiblues	01/04/2021 7:03:10 AM
71164	By measuring both groups at the same timeframes, (1)	CDiddy	01/04/2021 6:41:24 AM
71163	Yea I know but how can you prove the mortality (14)	Investor1.2	01/04/2021 6:17:12 AM
71162	The study has specified criteria to determine the	docj	01/04/2021 6:15:55 AM
71161	Mortality within the 28 day trial period,	CTMedic	01/04/2021 6:15:08 AM
71160	A question: The primary endpoint of cydy is (5)	Investor1.2	01/04/2021 6:13:48 AM
71159	$CYDY ICYMI	TonyCorvette	01/04/2021 6:11:15 AM
71158	Conference call reposted. Added emphasis for a (2)	CTMedic	01/04/2021 6:01:53 AM
71157	Correction to inclusion/exclusion criteria for (4)	docj	01/04/2021 6:01:45 AM
71156	CYDY mention in this SA piece: (2)	docj	01/04/2021 5:59:27 AM
71154	There is a danger trying to think how to "hack (4)	jamming1092	01/04/2021 3:58:15 AM
71153	SeeWhy, It would appear that his screen name is	CTMedic	01/04/2021 12:05:11 AM
71152	SP, that made my day! I really hope JTFs (1)	SeeWhyDY	01/03/2021 11:57:42 PM
71151	So you need full approval in order to generate $$	Boatbuilder	01/03/2021 11:54:54 PM
71148	Haha..exactly Nor worth the time	Shelly2626	01/03/2021 11:14:35 PM
71146	I know exactly what you are talking about my 2	Longestyard	01/03/2021 11:06:00 PM
71145	You are better off not. It's a complete waste of (5)	CDiddy	01/03/2021 11:00:59 PM
71144	I haven't ever been to ihub, only heard negative (4)	Longestyard	01/03/2021 10:42:25 PM
71143	The only answer I can come up with is that board	Lionel_Joseph	01/03/2021 10:28:33 PM
71142	Why havent you called me a tinfoil hate guy	Riztheinvestor	01/03/2021 10:25:06 PM
71141	Very true it spreading at an alarming rate and	Riztheinvestor	01/03/2021 10:17:44 PM
71140	Shelly I would offer that you complain to the	CTMedic	01/03/2021 10:13:02 PM
71138	I posted 3 times on ihub today ...all positive (3)	Shelly2626	01/03/2021 10:11:12 PM
71136	I dont see a full approval first. I see a EUA (4)	Goosebumps	01/03/2021 9:57:28 PM

Newer

Older

Recent Articles

• The Incredible Growth of Booz Allen Hamilton Over a Decade
• US Treasury May Face Critical Debt Limit Challenge Ahead
• Q-Gold Resources Completes Successful Financing Round for Growth
• Discovering the Growth of $1000 in Verisk Analytics Investment
• Big Lots Announces Strategic Asset Transfer to Retail Partners
• Trump Seeks Supreme Court Intervention on TikTok Law
• Lifeward's Upcoming Shareholder Meeting Set for January 2025
• Fobi AI's Strategic Move: Proposed Placement and BCSC Response
• Investigation Launched: MediaAlpha Inc. Faces Serious Allegations
• Opdivo Qvantig™ Approved: A Game-Changer in Cancer Care
• Investigation Launched into e.l.f. Beauty, Inc. Allegations
• Investigation Into Oklo Inc. Sparks Concerns for Investors
• Univest Securities Secures Successful $2.8 Million Offering
• Exploring Innovations in Toxicology at Upcoming ACMT Meeting
• Clear Blue Technologies Unveils Strategic Financial Restructuring
• Abaxx Technologies Strengthens Position in MineHub Shares
• Genius Group Reports Significant Growth in Assets for 2024
• VR Resources Completes Private Placement to Fuel Exploration Work
• Investigation Alerts for Spyre Therapeutics Investors Amid Concerns
• Investigation Launched for Arvinas, Inc. Investors Amid Concerns
• Investigation of Codere Online Luxembourg, S.A. Investors' Claims
• Blue Origin's New Glenn Rocket Launch License Approved
• Workers in Brazil Secure Support Amid BYD's Controversy
• Russia's Alleged Role in Azerbaijan Airlines Crash Raises Concerns
• Understanding Your Rights if You Lost in IMX Tokens
• Exploring the Profitability of Fluor Stock Over Five Years
• Advocating for Equity and Diversity in Neuroscientific Studies
• Ascend Wellness Holdings Reveals New Share Buyback Initiative
• University of Phoenix Launches Pathways for Workforce Growth
• Citius Pharmaceuticals' Growth Outlook Amid Strong 2024 Results
• Investigation Launched for Shareholders of Sana Biotechnology
• Citius Oncology's 2024 Financial Overview: Major Developments
• Investigation of Celanese Corporation: A Closer Look at CE
• Investigation into Airship AI Holdings, Inc. Claims by Law Firm
• Data Security Incident Notice by The Baker Center for Families
• Citius Oncology's Annual Performance: A Year of Strategic Growth
• Citius Pharmaceuticals Reflects on 2024 Financial Performance
• Willow Lane Acquisition Corp. Enables Independent Trading of Units
• Investigation of Innovative Industrial Properties: What Investors Should Know
• Ascend Wellness Holdings Initiates Strategic Share Buyback Program
• Investigation of Neurogene Inc. Raises Concerns for Investors
• OpenAI Transitions to Public Benefit Corporation for Growth
• Vanguard and US Bank Regulator Agree on Control Measures
• Luna Innovations Welcomes New Opportunities After Board Change
• Unlocking the Value of $1000 Invested in Murphy USA Today
• Market Trends and Stock Movements: Insights to Consider Now
• Investigation of Claims for First Northwest Bancorp Investors
• Flanigan's Enterprises Achieves Significant Revenue Growth
• Radius Recycling Sets Earnings Report and Webcast for 2025
• Aimfinity Investment Corp. I Extends Merger Deadline to 2025